| Can Resistance Enhance Selection of Treatment? (CREST) (NCT00262717) | Kirby Institute | 2001-03-01 |
| HCV/HIV Coinfection: Antiviral Therapy and Fibrosis (NCT01423643) | Johns Hopkins University | 2001-03-01 |
| Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients (NCT00013702) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |
| HIV Maintenance Therapy With T-20 During HAART Interruption (NCT00013884) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |
| Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study) (NCT00013611) | University of Minnesota | 2001-03-01 |
| The Effect of Milk Thistle on the Pharmacokinetics of Indinavir (NCT00011635) | National Institutes of Health Clinical Center (CC) | 2001-02-01 |
| Kidney Transplant for HIV-Infected Patients in Renal Failure (NCT00009009) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2001-01-01 |
| Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs (NCT00006494) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-07 |
| Capravirine to Treat Children With HIV Infection (NCT00006519) | National Cancer Institute (NCI) | 2000-11-01 |
| BASTA Study on STI in HIV Infected Patients (NCT00310245) | A.O. Ospedale Papa Giovanni XXIII | 2000-11-01 |
| An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection (NCT00162227) | Bristol-Myers Squibb | 2000-09-01 |
| Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women (NCT00006320) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-09-01 |
| HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection (NCT00196651) | French National Agency for Research on AIDS and Viral Hepatitis | 2000-08-01 |
| Impact of HIV on Measles and Measles Immunisation (NCT00247091) | Johns Hopkins Bloomberg School of Public Health | 2000-05-01 |
| Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs (NCT00005673) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-05-01 |
| Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy (NCT00009256) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-04-13 |
| Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV (NCT00004846) | National Institutes of Health Clinical Center (CC) | 1999-12-01 |
| A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy (NCT00001948) | National Institutes of Health Clinical Center (CC) | 1999-12-01 |
| Intermittent Versus Continuous Medication in the Treatment of HIV (NCT00001967) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-11-01 |
| Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593) | Fred Hutchinson Cancer Center | 1999-11-01 |
| Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer (NCT00005785) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-09-01 |
| Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor (NCT00001826) | National Cancer Institute (NCI) | 1999-07-01 |
| Combination Drug Treatment of Pediatric HIV Infection (NCT00001818) | National Cancer Institute (NCI) | 1999-06-01 |
| Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy (NCT00001899) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-12-16 |
| Drug Interactions Among Anti-HIV Agents (NCT00001766) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-08-01 |
| Magnetic Resonance Imaging of the Face and Bones (NCT00001762) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-02-23 |
| Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan (NCT00001712) | National Institutes of Health Clinical Center (CC) | 1998-02-01 |
| A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine (NCT00001688) | National Cancer Institute (NCI) | 1998-01-01 |
| Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz (NCT00001758) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-11-01 |
| Evaluation of the Safety of a Polyvalent Virus in Healthy Adults (NCT00187044) | St. Jude Children's Research Hospital | 1997-10-01 |
| Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients (NCT00001650) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-09-19 |
| White Blood Cell Infusions to Treat HIV Infection (NCT00001647) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire (NCT01917175) | ANRS, Emerging Infectious Diseases | 1997-06-01 |
| Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection (NCT00001644) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-03-03 |
| Immune Activity Against CVM Retinitis (NCT00001611) | National Eye Institute (NEI) | 1997-02-01 |
| Thalidomide to Treat Oral Lesions in HIV-Infected Patients (NCT00001524) | National Institute of Dental and Craniofacial Research (NIDCR) | 1996-06-01 |
| Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits (NCT00001500) | National Cancer Institute (NCI) | 1996-04-01 |
| Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers (NCT00001538) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-03-01 |
| Twins Study of Gene Therapy for HIV Infection (NCT00001535) | National Human Genome Research Institute (NHGRI) | 1996-03-01 |
| Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection (NCT00001445) | National Cancer Institute (NCI) | 1995-08-01 |
| Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist (NCT00001475) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-06-01 |
| Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients (NCT00001474) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-05-01 |
| Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications (NCT00001409) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-09-01 |
| Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection (NCT00001386) | National Cancer Institute (NCI) | 1994-06-01 |
| Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients (NCT00001357) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-08-01 |
| Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs (NCT00001353) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-03-01 |
| Interleukin-2 Therapy for HIV Infection - Supplemental Procedures (NCT00001354) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-03-01 |
| Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens (NCT00001294) | National Cancer Institute (NCI) | 1992-01-01 |
| A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients (NCT00001282) | National Institute of Allergy and Infectious Diseases (NIAID) | 1991-07-01 |
| Study of Patients With Strongyloides Stercoralis Infection (NCT00001245) | National Institute of Allergy and Infectious Diseases (NIAID) | 1989-08-01 |
| Effects of HIV on the Development and Function of Bone Marrow Cells (NCT00001243) | National Institute of Allergy and Infectious Diseases (NIAID) | 1989-02-01 |
| Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects (NCT00091741) | Georgetown University | |
| Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring (NCT01555723) | University of Wisconsin, Madison | |
| A Medication Adherence Intervention for HIV Infected Veterans (NCT00013065) | US Department of Veterans Affairs | |
| Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz. (NCT00386659) | Hospital Clinic of Barcelona | |
| A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects (NCT00121017) | Abbott | |